Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

• Status: Recruiting
• Trial end date: 2022-04-01

Summary

Optical Coherent Tomography Angiography (OCTA)-Directed PDT Triple Therapy for Treatment-Naïve Patients with Exudative Age-related Macular Degeneration (ARMD) versus Standard of Care Anti-VEGF Monotherapy

• Phase: Phase 4

Details

• Lead Sponsor: Wake Forest University Health Sciences
• Treatments: Ranibizumab; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide; Verteporfin